We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.43%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$617M
AUM Growth
-$413M
Cap. Flow
-$455M
Cap. Flow %
-73.77%
Top 10 Hldgs %
54.35%
Holding
5,864
New
1,647
Increased
1,144
Reduced
1,785
Closed
1,178

Sector Composition

Rank Sector Weight
1 Financials 1.97%
2 Technology 1.44%
3 Real Estate 1.39%
4 Energy 1.34%
5 Industrials 1.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALG icon
2076
Alamo Group
ALG
$2.05B
$10K ﹤0.01%
200
-1,884
-90% -$96.9K
AMT icon
2077
American Tower
AMT
$80.4B
$10K ﹤0.01%
+100
New +$9.74K
ASMB icon
2078
Assembly Biosciences
ASMB
$529M
$10K ﹤0.01%
114
+1
+0.9% +$109
ASML icon
2079
ASML
ASML
$669B
$10K ﹤0.01%
110
-1,698
-94% -$155K
AVNT icon
2080
Avient
AVNT
$4.19B
$10K ﹤0.01%
300
-1,326
-82% -$44.3K
AWP
2081
abrdn Global Premier Properties Fund
AWP
$367M
$10K ﹤0.01%
598
+475
+386% +$8.43K
BDC icon
2082
Belden
BDC
$5.19B
$10K ﹤0.01%
210
+10
+5% +$550
BBT
2083
Beacon Financial Corp
BBT
$2.66B
$10K ﹤0.01%
+338
New +$9.81K
BKH icon
2084
Black Hills Corp
BKH
$5.69B
$10K ﹤0.01%
210
-2,890
-93% -$127K
CENTA icon
2085
Central Garden & Pet Co Class A
CENTA
$2.44B
$10K ﹤0.01%
894
-77
-8% -$991
CHW
2086
Calamos Global Dynamic Income Fund
CHW
$545M
$10K ﹤0.01%
1,343
-1,446
-52% -$10.7K
CLDX icon
2087
Celldex Therapeutics
CLDX
$3.28B
$10K ﹤0.01%
+41
New +$8.94K
CNOB icon
2088
Center Bancorp
CNOB
$1.78B
$10K ﹤0.01%
+560
New +$10.3K
ELDN icon
2089
Eledon Pharmaceuticals
ELDN
$285M
$10K ﹤0.01%
+7
New +$12.2K
ELS icon
2090
Equity Lifestyle Properties
ELS
$12.6B
$10K ﹤0.01%
+312
New +$9.65K
EOT
2091
Eaton Vance National Municipal Opportunities Trust
EOT
$274M
$10K ﹤0.01%
+487
New +$10.4K
EQT icon
2092
EQT Corp
EQT
$32.3B
$10K ﹤0.01%
+367
New +$12.3K
EUFN icon
2093
iShares MSCI Europe Financials ETF
EUFN
$4.29B
$10K ﹤0.01%
+491
New +$10.4K
EVGN icon
2094
Evogene
EVGN
$7.26M
$10K ﹤0.01%
122
+112
+1,120% +$8.32K
FCEL icon
2095
FuelCell Energy
FCEL
$1.63B
$10K ﹤0.01%
5
-11
-69% -$35.4K
FL
2096
DELISTED
Foot Locker
FL
$10K ﹤0.01%
+153
New +$10.2K
FLC
2097
Flaherty & Crumrine Total Return Fund
FLC
$175M
$10K ﹤0.01%
+530
New +$10.2K
FN icon
2098
Fabrinet
FN
$20.1B
$10K ﹤0.01%
+399
New +$8.9K
FWDI
2099
Forward Industries Inc
FWDI
$319M
$10K ﹤0.01%
+667
New +$9.3K
FOXF icon
2100
Fox Factory Holding Corp
FOXF
$886M
$10K ﹤0.01%
612
+305
+99% +$5.4K

Similar funds

Tower Research Capital (TRC)'s Q4 2015 Portfolio in Review

As of Q4 2015, Tower Research Capital (TRC) held 5,864 positions worth $617M, down 40% from $1.03B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Tower Research Capital (TRC) withdrew a net $455M in Q4 2015, closing 1,178 positions and reducing 1,785 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $28.6M position sold in full.

By sector, the portfolio is most concentrated in Financials at 2% of assets, down from 2.2% a quarter earlier, followed by Technology and Real Estate.

Against the trend, Tower Research Capital (TRC) opened a new position in ProShares Short S&P500 worth $5.21M.

  • Tower Research Capital (TRC)'s largest Q4 2015 buy was ProShares Short S&P500: 31,192 shares worth $5.21M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2015, an estimated $17.5M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $203M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q4 2015, selling an estimated $28.6M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 54% of its $617M portfolio in Q4 2015.
  • Tower Research Capital (TRC) opened 1,647 new positions and closed 1,178 in Q4 2015.
  • Tower Research Capital (TRC)'s portfolio value fell 40% quarter-over-quarter to $617M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2015, filed 10 Feb 2016.